Pulmonary Function in Pulmonary Sarcoidosis
Journal of Clinical Medicine · 24.10.2023 · 12 (21) · 6701
DOI: 10.3390/jcm12216701 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Clinical Medicine, online erschienen am 24.10.2023. Verfasst von Qian Yao und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Research Unit, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai 200443, China. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 82 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Science Foundation of Shanghai, China, Science and Technology Innovation Research Project of Shanghai Science and Technology Commission, China, Clinical Research Plan of SHDC, Shanghai, China.
Abstract (Originalsprache)
The pulmonary function test (PFT) has been widely used in sarcoidosis. It may vary due to the severity, extent, and the presence of complications of the disease. Although the PFT of most sarcoidosis patients is normal, there are still 10–30% of cases who may experience a decrease in the PFT, with a progressive involvement of lungs. Restrictive ventilatory impairment due to parenchymal involvement has been commonly reported, and an obstructive pattern can also be present related to airway involvement. The PFT may influence treatment decisions. A diffusing capacity for carbon monoxide (DLCO) < 60% as well as a forced vital capacity (FVC) < 70% portends clinically significant pulmonary sarcoidosis pathology and warrants treatment. During follow-up, a 5% decline in FVC from baseline or a 10% decline in DLCO has been considered significant and reflects the disease progression. FVC has been recommended as the favored objective endpoint for monitoring the response to therapy, and an improvement in predicted FVC percentage of more than 5% is considered effective.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Clinical Research Unit, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai 200443, China.
- Department of Pulmonary and Critical Care Medicine, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai 200433, China.
ORCID-Profile: Qian Yao
Förderung
- National Science Foundation of Shanghai, China
- Science and Technology Innovation Research Project of Shanghai Science and Technology Commission, China
- Clinical Research Plan of SHDC, Shanghai, China
- National Natural Science Foundation of China, China
Zitieren
APA
Yao, Q., Ji, Q., & Zhou, Y. (2023). Pulmonary Function in Pulmonary Sarcoidosis. Journal of Clinical Medicine, 12(21), 6701. https://doi.org/10.3390/jcm12216701
Vancouver
Yao Q, Ji Q, Zhou Y. Pulmonary Function in Pulmonary Sarcoidosis. Journal of Clinical Medicine. 2023;12(21):6701. doi:10.3390/jcm12216701
BibTeX
@article{Yao2023,
author = {Yao, Qian and Ji, Qiuliang and Zhou, Ying},
title = {Pulmonary Function in Pulmonary Sarcoidosis},
journal = {Journal of Clinical Medicine},
year = {2023},
volume = {12},
number = {21},
pages = {6701},
doi = {10.3390/jcm12216701}
}
EUVIMED